Christopher Volker
Chief Operating Officer bij NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Vermogen: 90 000 $ op 31-03-2024
Profiel
Christopher R.
Volker is currently the Chief Operating Officer at NeuroOne Medical Technologies Corp.
Prior to this, he was the Vice President & General Manager-International at Cardiovascular Systems, Inc. from 2017 to 2023.
He also worked at Abbott Laboratories as the Head-Commercial Integration.
Mr. Volker completed his undergraduate degree at Saint John's University and earned an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-12-2023 | 75 000 ( 0.29% ) | 90 000 $ | 31-03-2024 |
Actieve functies van Christopher Volker
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Chief Operating Officer | 10-11-2023 |
Eerdere bekende functies van Christopher Volker
| Bedrijven | Functie | Einde |
|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | Corporate Officer/Principal | 01-08-2023 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-04-2023 |
Opleiding van Christopher Volker
| Saint John's University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
